An Observational Study on the Identification of Prescription Patterns of STAFEN Cap

Launched by HANLIM PHARM. CO., LTD. · Jan 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how doctors prescribe a medication called STAFEN Cap for patients with a condition called mixed dyslipidemia, which means they have unhealthy levels of fats in their blood. The study will observe changes in blood fat levels and any muscle symptoms that might be related to using statins, a common type of cholesterol medication. The trial is currently recruiting participants who are adults over 19 years old, have been diagnosed with mixed dyslipidemia, and are starting treatment with STAFEN Cap for the first time.

If you or someone you know is interested in participating, you would need to agree to be part of the study in writing. However, pregnant or breastfeeding women cannot participate, nor can those who are not allowed to take the medication for any reason. Participants will have the opportunity to help researchers understand how this medication works and how it affects patients, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults over 19 years of age
• • 2. A patient diagnosed with mixed dyslipidemia
• • 3. A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment
• • 4. A patient who voluntarily agreed in writing to this study
• Exclusion Criteria:
• • 1. Pregnant women, lactating women, or those planning to conceive
• • 2. A person who is prohibited from administering the STAFEN cap. under the permit
• • 3. If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study